Navigation Links
NJ stroke researchers report advances in spatial neglect research at AAN Conference
Date:4/10/2012

West Orange, NJ. April 11, 2012. Anna M. Barrett, MD will represent Kessler Foundation's Stroke Rehabilitation Research Laboratory at the upcoming American Academy of Neurology Conference at the Ernest N. Morial Convention Center in New Orleans, LA, April 21 April 28. Four abstracts will be presented representing the Laboratory's collaborative investigation of the neurocognitive disorder of spatial neglect after right-brain stroke. Spatial neglect is a hidden disability of functional vision that hinders rehabilitation and recovery, affecting up to half of stroke survivors in the days and weeks after stroke.

Kessler Foundation's Stroke Rehabilitation Research Laboratory is a leader in establishing new clinical practice guidelines to reliably identify and treat this disabling disorder, through the Kessler Foundation Neglect Assessment Process (KF-NAP), which will be presented at the meeting. A.M. Barrett, MD, Director of Stroke Rehabilitation and Peii Chen, PhD, research scientist at Kessler Foundation will be presenting on this process with Kessler Foundation's collaborators, including Kimberly Hreha, OTR, Kessler Institute for Rehabilitation, Anne Foundas, MD, LSU Health Sciences Center, Louisiana State University, Kelly Goedert, PhD, Seton Hall University, Raymond Boston, PhD, University of Pennsylvania, Priyanka Shah and Amit Chaudhari, University of Medicine & Dentistry of New Jersey, and Paola Fortis, PhD, Center for Neurocognitive Rehabilitation, University of Trento, Italy. Dr. Barrett, a Professor at UMDNJ-New Jersey Medical School and Chief of Neurorehabilitation Program Innovation at Kessler Institute, is also the current president of the American Society for Neurorehabilitation (ASNR).

The Kessler Foundation Stroke Research Laboratory applies advances in spatial neglect research to clinical care, and will present two abstracts on the exciting prism treatment approach to this disorder. "Our goal is to develop guidelines for assigning prism treatment, based on behavior or brain imaging during the first weeks after stroke," commented Dr. Chen. The Stroke Laboratory raises professional awareness of this under-recognized stroke complication through the multidisciplinary Network for Spatial Neglect. The Network for Spatial Neglect was launched at the 2011 ASNR conference by Drs. Barrett and Chen, Kimberly Hreha, and Robin Hedeman of Kessler Institute.

Topics for the upcoming AAN meeting are:

  • Chen P, Hreha K, Fortis P, Goedert KM, Barrett AM. Using the Catherine Bergego Scale (CBS) in rehabilitation of spatial neglect: Kessler Foundation Neglect Assessment Process (KF-NAP).
  • Barrett AM, Goedert KM, Chen P, Boston R. Dissociated response to prism adaptation "aiming" spatial-motor bias, not "where" perceptual-attentional bias, is key.
  • Chaudhari A, Chen P, Goedert KM, Barrett AM. Retrospective analysis suggests BIT may sensitively diagnose "Where" perceptual-attentional neglect, in stroke survivors having less disability.
  • Shah P, Chen P, Goedert KM, Foundas AL, Barrett AM. Integrity of medial visuomotor pathway predicts better recovery in neglect patients receiving prism adaptation treatment.


'/>"/>

Contact: Carolann Murphy
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Related medicine news :

1. Could Menthol Cigarettes Pose Even Higher Stroke Risk?
2. Predictors identified for rehospitalization among post-acute stroke patients
3. Stroke experts write a doctors guide for minimizing the risk of stroke
4. When Paramedics Suspect Stroke, Theyre Usually Right
5. Closing hole in the heart no better than drugs in preventing strokes
6. Half of Stroke Victims Dont Call 911, Research Shows
7. Art improves stroke survivors quality of life
8. Moderate drinking associated with lower risk of stroke in women
9. Study finds expensive procedure no more effective than medical therapy to prevent strokes
10. Brain Scans Overused on U.S. Stroke Patients, Study Says
11. Physicians order costly, redundant neuroimaging for stroke patients, study says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: